Atypical follicular hyperplasia with light chain–restricted germinal centers after COVID-19 booster: a diagnostic pitfall

[1]  N. Yaqoob,et al.  A study of plithogenic graphs: applications in spreading coronavirus disease (COVID-19) globally , 2022, Journal of ambient intelligence and humanized computing.

[2]  A. Kwong,et al.  COVID-19 vaccine associated axillary lymphadenopathy – A systematic review , 2022, Cancer Treatment and Research Communications.

[3]  A. Boccatonda,et al.  Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features , 2022, Medicina.

[4]  Sa'ad Laws,et al.  Lymphadenopathy post‐COVID‐19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review , 2022, Journal of medical virology.

[5]  A. Wee,et al.  Kikuchi–Fujimoto Disease Post COVID-19 Vaccination: Case Report and Review of Literature , 2021, Vaccines.

[6]  H. Kang,et al.  COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature , 2021, Seminars in Oncology.

[7]  S. Swerdlow,et al.  Light Chain-Restricted Plasmacytoid Cells in Hyperplastic Germinal CentersA Clinicopathologic Investigation. , 2021, American journal of clinical pathology.

[8]  Urvish K. Patel,et al.  COVID-19: a Disease with a Potpourri of Histopathologic Findings—a Literature Review and Comparison to the Closely Related SARS and MERS , 2021, SN Comprehensive Clinical Medicine.

[9]  M. Maslamani,et al.  Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report , 2021, IDCases.

[10]  M. Bahmanyar,et al.  Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review , 2021, Journal of the Neurological Sciences.

[11]  A. Rodríguez-Morales,et al.  Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems , 2021, Drugs & Therapy Perspectives.

[12]  M. Lynch,et al.  ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine , 2021, American Journal of Kidney Diseases.

[13]  Duygu Gulseren,et al.  New‐onset leukocytoclastic vasculitis after COVID‐19 vaccine , 2021, International journal of dermatology.

[14]  L. Alberio,et al.  COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia , 2021, Hämostaseologie.

[15]  F. Yazdanpanah,et al.  Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review , 2021, Academic Radiology.

[16]  J. Oldenburg,et al.  Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH , 2021, Hämostaseologie.

[17]  J. Ellermann,et al.  Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncology Patients , 2021, Radiology.

[18]  S. Goldberg,et al.  Lymphadenopathy Associated With the COVID-19 Vaccine , 2021, Cureus.

[19]  M. Locci,et al.  SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond , 2021, Vaccines.

[20]  D. Weissman,et al.  SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation , 2020, Immunity.

[21]  William F. Fadel,et al.  Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study , 2020, medRxiv.

[22]  S. Sekaran,et al.  The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2 , 2020, Biochimie.

[23]  P. Hofman,et al.  Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists , 2020, Virchows Archiv.

[24]  H. Karakuła-Juchnowicz,et al.  COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge , 2020, Journal of clinical medicine.

[25]  T. de Giacomo,et al.  Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen , 2020, Virchows Archiv.

[26]  P. Zhou,et al.  Histopathologic Changes and SARS–CoV-2 Immunostaining in the Lung of a Patient With COVID-19 , 2020, Annals of Internal Medicine.

[27]  R. Trimble.  COVID-19 Dashboard , 2020 .

[28]  Haibo Xu,et al.  Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer , 2020, Journal of Thoracic Oncology.